Πλοήγηση ανά Συγγραφέα "Geitona, M."
-
Colocteral cancer management and prevention policies in Greece
Geitona, M.; Kanavos, P. (2010)Despite lower cancer mortality rates in Greece compared to other European countries, colorectal cancer (CRC) is the third most important cause of cancer mortality. Given the significant economic and societal impact of CRC ... -
Cost estimation of neonatal intensive care in Greece: The case of Athens maternity hospitals
Geitona, M.; Hatzikou, M. (2007)This study aimed to estimate the hospitalisation costs for neonatal intensive care and to investigate any discrepancies with reimbursement by the social funds in Greece. The study was based on a prospective selection of ... -
Cost estimation of patients admitted to the intensive care unit: A case study of the Teaching University Hospital of Thessaly
Geitona, M.; Androutsou, L.; Theodoratou, D. (2010)Objective: This study aimed to estimate the cost of patients admitted to the Intensive Care Unit (ICU) of the Teaching University Hospital of Thessaly (TUHT) in 2006 and to demonstrate discrepancies between actual ... -
The cost of prematurity: Two neonatal intensive care units (NICUs) from university hospitals of Athens
Hatzikou, M.; Halkos, G.; Hatzistamatiou, Z.; Geitona, M. (2005) -
COST OF TREATING PATIENTS WITH OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYDROME IN THE SOTIRIA CHEST HOSPITAL IN GREECE
Prapa, P.; Geitona, M.; Gourgoulianis, K. (2012) -
Cost-effectiveness of hypertension treatment in Greece: The ECON-APROS study
Kyriopoulos, J.; Athanasakis, K.; Zavras, A.; Angeli, A.; Geitona, M. (2007) -
Cost-Minimisation Analysis of Oral Anticoagulant Therapy Monitoring Methods: The Case for Prothrombin Time Self-Monitoring
Geitona, M.; Hollandezos, M.; Souliotis, K.; Athanasakis, K.; Kyriopoulos, J. (2008)Introduction: Anticoagulant therapy is usually chronic and is indicated for the treatment of several medical conditions. The most common of these include patients with mechanical heart valves and those suffering from atrial ... -
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study
Geitona, M.; Kousoulakou, H.; Ollandezos, M.; Athanasakis, K.; Papanicolaou, S.; Kyriopoulos, I. (2008)Background: To compare the costs and effects of paliperidone extended release (ER), a new pharmaceutical treatment for the management of schizophrenia, with the most frequently prescribed oral treatments in Greece (namely ... -
Determinants of healthcare utilization in Greece: Implications for decision-making
Geitona, M.; Zavras, D.; Kyriopoulos, J. (2007)Objective: To explore factors influencing the utilization of primary and secondary healthcare in Greece. Methods: A national, geographically stratified sample was randomly selected. From November 2001 to March 2002, 5000 ... -
DIRECT COST OF TREATING PATIENTS WITH SCHIZOPHRENIA IN GREECE: REAL-WORLD DATA FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY (E-STAR)
Geitona, M.; Kousoulakou, C.; Ollandezos, M.; Papanicolaou, S.; Athanasakis, K.; Tsiantou, V.; Kyriopoulos, J. (2008) -
The economic burden of treating neonates in Intensive Care Units (ICUs) in Greece
Geitona, M.; Hatzikou, M.; Hatzistamatiou, Z.; Anastasiadou, A.; Theodoratou, T. D. (2007)Background: In a period when a public-private mix in Greece is under consideration and hospital budgets become restrained, economic assessment is important for rational decision making. The study aimed to estimate the ... -
Economic evaluation between alternative patterns of outpatient care in Greece: The case of IKA insurance fund
Geitona, M.; Sotirchou, N. (2004) -
Economic evaluation of tiotropium and salmeterol in the treatment of COPD in Greece
Maniadakis, N.; Tzanakis, N.; Geitona, M.; Fragoulakis, V.; Hatzikou, M.; Siafakas, N. (2005) -
Efficiency assessment across homogeneous specialty clinics in the region of thessaly, Greece
Geitona, M.; Androutsou, L.; Yfantopoulos, J. (2012)Background: Hospital care expenditure is the most significant cost driver in the health care sector. Reductions in public hospitals' expenses are among the principal austerity measures included in the memorandum recommendations. ... -
Erratum: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study (Annals of General Psychiatry)
Geitona, M.; Kousoulakou, H.; Ollandezos, M.; Athanasakis, K.; Kyriopoulos, I.; Papanicolaou, S. (2009) -
Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost
Athanasakis, K.; Ollandezos, M.; Angeli, A.; Gregoriou, A.; Geitona, M.; Kyriopoulos, J. (2010)Aims To estimate the annual cost of treatment for Type 2 diabetic patients in Greece and investigate the effect of blood glucose regulation on patient cost. Methods A multipoint data collection procedure based on the patient ... -
ESTIMATING THE DIRECT COST OF TYPE II DIABETES IN GREECE
Athanasakis, K.; Ollandezos, M.; Angeli, A.; Gregoriou, A.; Geitona, M.; Kyriopoulos, J. (2008) -
EVALUATION OF THE AFTERNOON OUTPATIENT CLINICS OPERATION AT THE UNIVERSITY HOSPITAL IN LARISA
Geitona, M.; Androutsou, L.; Mpouki, L. (2008) -
Generic medicines: Greek physicians' perceptions and prescribing practices
Tsiantou, V.; Zavras, D.; Kousoulakou, H.; Geitona, M.; Kyriopoulos, J. (2009)P>Background and objective: The penetration of generic drugs in the Greek pharmaceutical market is placed among the weakest in the EU. The Greek regulatory framework does not systematically support the development of this ... -
Generics market in Greece: The pharmaceutical industry's beliefs
Geitona, M.; Zavras, D.; Hatzikou, M.; Kyriopoulos, J. (2006)The aim of this study was to investigate the beliefs and perspectives of the pharmaceutical industry on generic medication in Greece. Questionnaires were mailed to all 58 members of the Hellenic Association of Pharmaceutical ...